MLYS CIK: 1933414

Mineralys Therapeutics, Inc.

  • United States
  • Healthcare
  • Biotech
Metrics score locked — part of Premium
FY22
FY23
FY24
FY25
FY22 – FY25

Assets

(positive)
Change from FY22 to FY25
millions USD
FY22:
113
FY23:
249
FY24:
205
FY25:
661
(positive)
Change from FY22 to FY25
millions USD
FY22:
1.63
FY23:
2.53
FY24:
0.55
FY25:
0.42
Total assets
Change from FY22 to FY25
millions USD
FY22:
114
FY23:
252
FY24:
206
FY25:
662

Liabilities & Equity

(negative)
Change from FY22 to FY25
millions USD
FY22:
8.07
FY23:
10.5
FY24:
14.6
FY25:
15.1
(negative)
Change from FY22 to FY25
millions USD
FY22:
159
FY23:
0
FY24:
0
FY25:
0
(positive)
Change from FY22 to FY25
millions USD
FY22:
−52.3
FY23:
241
FY24:
191
FY25:
647
Total liabilities & equity
Change from FY22 to FY25
millions USD
FY22:
114
FY23:
252
FY24:
206
FY25:
662

All amounts in millions USD Data sources:SEC EDGARTwelve Data